BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation

  May 4, 2026

   · 

  3 min read
• Press Releases

  Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 1, 2026

  May 4, 2026

   · 

  2 min read
• Press Releases

  Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 1, 2026

  May 4, 2026

   · 

  1 min read
• Press Releases

  Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 1, 2026

  May 4, 2026

   · 

  1 min read
• Press Releases

  INOVIO to Report First Quarter Financial Results on May 13, 2026

  May 4, 2026

   · 

  1 min read
• Press Releases

  BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society’s 2026 Annual Meeting

  May 4, 2026

   · 

  12 min read
• Press Releases

  UCB to Acquire Candid Therapeutics, Building Upon Its Existing Immunology Pipeline With Novel T-cell Engagers

  May 4, 2026

   · 

  9 min read
• Press Releases

  Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

  May 4, 2026

   · 

  5 min read
• Press Releases

  Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026

  May 4, 2026

   · 

  1 min read
• Press Releases

  Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate

  May 4, 2026

   · 

  4 min read